Taylor & Francis Online: Weight of Evidence Evaluation for Chemical-Induced Immunotoxicity for PFOA and PFOS

May 5, 2023


Stay up to date on our latest insights and research by signing up for our Monthly Roundups. We will send our monthly updates directly to your inbox.

Council member Janet Anderson and members of her consulting firm GSI Environmental Inc., recently collaborated with SciPinion to provide an expert panel of toxicologists and public health scientists to summarize and draw conclusions from the current scientific knowledge on immunotoxicity and PFOA and PFOS.

The expert panel agreed that while immunotoxicity is a relevant toxic endpoint for PFOA and PFOS exposure, the current scientific data do not support EPA’s use of immunotoxicity (and the epidemiological studies on which they relied) for establishing risk-based criteria for PFOA and PFOS.

Immunotoxicity is the critical endpoint used by the some regulatory agencies to establish toxicity values for perfluorooctanoic acid (PFOA) and perfluorooctane sulfonate (PFOS). However, the hypothesis that exposure to certain per- and polyfluoroalkyl substances (PFAS) causes immune dysregulation is subject to much debate. An independent, international expert panel was engaged utilizing methods to reduce bias and “groupthink.” The panel concluded there is moderate evidence that PFOS and PFOA are immunotoxic, based primarily on evidence from animal data. However, species concordance and human relevance cannot be well established due to data limitations. The panel recommended additional testing that includes longer-term exposures, evaluates both genders, includes other species of animals, tests lower dose levels, assesses more complete measures of immune responses, and elucidates the mechanism of action. Panel members agreed that the Faroe Islands cohort data should not be used as the primary basis for deriving PFAS risk assessment values. The panel agreed that vaccine antibody titer is not useful as a stand-alone metric for risk assessment. Instead, PFOA and PFOS toxicity values should rely on multiple high-quality studies, which are currently not available for immune suppression. The panel concluded that the available PFAS immune epidemiology studies suffer from weaknesses in study design that preclude their use, whereas available animal toxicity studies provide comprehensive dataset to derive points of departure (PODs) for non-immune endpoints. The panel recommends accounting for potential PFAS immunotoxicity by applying a database uncertainty factor to POD values derived from animal studies for other more robustly supported critical effects.

Read the full publication here.

Read more water news:

Pin It on Pinterest

Share This
Monthly Roundup